Fusion of a Kinase Gene, <i>ALK</i> , to a Nucleolar Protein Gene, <i>NPM</i> , in Non-Hodgkin's Lymphoma

Stephan W. Morris(St. Jude Children's Research Hospital), Mark N. Kirstein(St. Jude Children's Research Hospital), Marcus B. Valentine(St. Jude Children's Research Hospital), K. Dittmer(St. Jude Children's Research Hospital), David N. Shapiro(St. Jude Children's Research Hospital), David L. Saltman(Box (United States)), A. Thomas Look(St. Jude Children's Research Hospital)
Science
March 4, 1994
Cited by 2,401

Abstract

The 2;5 chromosomal translocation occurs in most anaplastic large-cell non-Hodgkin's lymphomas arising from activated T lymphocytes. This rearrangement was shown to fuse the NPM nucleolar phosphoprotein gene on chromosome 5q35 to a previously unidentified protein tyrosine kinase gene, ALK, on chromosome 2p23. In the predicted hybrid protein, the amino terminus of nucleophosmin (NPM) is linked to the catalytic domain of anaplastic lymphoma kinase (ALK). Expressed in the small intestine, testis, and brain but not in normal lymphoid cells, ALK shows greatest sequence similarity to the insulin receptor subfamily of kinases. Unscheduled expression of the truncated ALK may contribute to malignant transformation in these lymphomas.


Related Papers

No related papers found

Powered by citation graph analysis